PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- DILANTIN
- Generic name / active ingredient
- extended phenytoin sodium capsules
- Dosage-form class
- This dossier covers only DILANTIN extended phenytoin sodium capsules. Oral suspension, chewable tablets, prompt-release capsules, fosphenytoin injection and other manufacturers' products are not the same exact product. Formulation or brand changes require professional monitoring and cannot be self-substituted by a shared ingredient or total milligrams.
- Route
- Oral
- Record reviewed
- 2026-09-05
Copy from the pack in hand
Source-linked reading points
- Do not abruptly stop, double after a missed dose, rotate brands or replace extended capsules with another form. Brand or dosage-form changes may alter absorption and require professionally planned phenytoin-level and clinical monitoring.
- Nystagmus, unsteady walking, slurred speech, drowsiness or mental-status change may signal neurologic toxicity. Do not self-adjust from a webpage; contact a healthcare professional promptly.
- Severe rash, blistering, mucosal injury, swelling of the face/lips/tongue/throat, or fever with rash or lymph-node enlargement may involve severe skin reactions, DRESS or angioedema and needs urgent medical assessment.
- Phenytoin has many interactions. Prescriptions, OTC medicines, herbs, supplements, alcohol use and nutrition support should be reviewed together by a doctor or pharmacist; simply spacing doses is insufficient.
Reviewed presentation examples — compare every field
- Phenytoin sodium 30 mg per capsule; 100-capsule bottleNDC 58151-118-01
- Phenytoin sodium 100 mg per capsule; 100-capsule bottleNDC 58151-110-01